Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma
Cazzanelli, G., Dalle Vedove, A., Broso, F., Burigotto, M., Aiello, G., Ruzzene, M., Tiberi, L., Fava, L., Quattrone, A., Lolli, G.To be published.